aTYR PHARMA (ATYR) Minority Interest (2019 - 2026)
aTYR PHARMA's (ATYR) quarterly Minority Interest came in at -$193000.0 in Q1 2026, down 2.66% YoY from -$198273.2 in Q1 2025, and down 0.52% on a QoQ basis from -$192000.0 in Q4 2025.
aTYR PHARMA (ATYR) Minority Interest (2019 - 2026) Analysis & Trends
aTYR PHARMA (ATYR) has 8 years of Minority Interest data on file, last reported at -$193000.0 in Q1 2026.
- Quarterly Minority Interest fell 2.66% year-over-year to -$193000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$193000.0 (down 2.66% YoY) and the FY2025 annual result came in at -$192000.0, down 2.67% from the prior year.
- Minority Interest fell to -$193000.0 in Q1 2026, from -$192000.0 in the prior quarter.
- In the past five years, Minority Interest ranged from a high of -$176000.0 in Q1 2022 to a low of -$193000.0 in Q1 2026.
- A 5-year average of -$185058.8 and a median of -$186000.0 in 2024 frame the typical range for Minority Interest.
- Annual changes were most pronounced in 2023 — Minority Interest declined 5.06% — and 2024, when it gained 0.54%.
- Tracing ATYR's Minority Interest over 5 years: stood at -$180000.0 in 2022, then retreated by 4.44% to -$188000.0 in 2023, then climbed by 0.53% to -$187000.0 in 2024, then fell by 2.67% to -$192000.0 in 2025, then decreased by 0.52% to -$193000.0 in 2026.
- The last three Minority Interest figures came in at -$193000.0 (Q1 2026), -$192000.0 (Q4 2025), and -$191000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | aTYR PHARMA | 49.54 Mn | -7.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -194,000.00 |
| Mar 31, 2026 | -193,000.00 |
| Dec 31, 2025 | -192,000.00 |
| Sep 30, 2025 | -191,000.00 |
| Jun 30, 2025 | -189,000.00 |
| Mar 31, 2025 | -188,000.00 |
| Dec 31, 2024 | -187,000.00 |
| Sep 30, 2024 | -186,000.00 |
| Jun 30, 2024 | -184,000.00 |
| Mar 31, 2024 | -184,000.00 |
| Dec 31, 2023 | -188,000.00 |
| Sep 30, 2023 | -187,000.00 |
| Jun 30, 2023 | -185,000.00 |
| Mar 31, 2023 | -181,000.00 |
| Dec 31, 2022 | -180,000.00 |
| Sep 30, 2022 | -178,000.00 |
| Jun 30, 2022 | -177,000.00 |
| Mar 31, 2022 | -176,000.00 |
| Dec 31, 2021 | -175,000.00 |
| Sep 30, 2021 | -173,000.00 |